May 2013 FDA Recall Drug by Sandoz Incorporated
D-832-2013 - Presence of Particulate Matter

This Class I drug recall was voluntarily initiated by Sandoz Incorporated on May 20, 2013 for the product Drug. The FDA reported the reason for recall as presence of particulate matter. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-832-2013

Reason for Recall
Presence of Particulate Matter: Found during examination of retention samples.
Initiated
05-20-2013
Reported
08-14-2013
Quantity
1,635 vials

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Methotrexate Injection, USP, Preservative-Free, 1 g/40 mL (25 mg/mL), 40 mL Single Dose Vial, Rx only, Manufactured for: Sandoz Inc., Princeton, NJ 08540; Manufactured by: EBEWE Pharma Ges.m.b.H. Nfg.KG, A-4866 Unterach, AUSTRIA, NDC 66758-041-01.

Batch or Lot Expiration Information

Lot# : CL0996, Exp 12/13; and CJ4948, Exp 05/13